Healthier Choices Management Corp.
Datakwaliteit: 100%
HCMC
OTC
Manufacturing
Tobacco
€ 0,00
€ 0,00
(0,00%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-87,77%
Groei
Revenue Growth (5Y)
-87,77%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)494,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net Margin-235580,56%
Op. Margin-236084,16%
Veiligheid
Debt / Equity
N/A
Current Ratio0,27
Interest Coverage-202,44
Waardering
PE (TTM)
-7,51
Onder sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -87,77% annually over 5 years
Negative free cash flow of -3,93 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 582,38%
Capital intensive — 1583,92% of revenue goes to capex
Price History
Financiële Trends
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstverassingen
EPS
Reported
Estimate
| Q12014 | Q22014 | Q32014 | Q42014 | |
|---|---|---|---|---|
| Reported | -€ 630.000,60 | -€ 420.000,40 | -€ 2.030.002,00 | -€ 2.800.002,80 |
| Estimate | € 140.000,14 | € 0,00 | -€ 490.000,50 | — |
| Verrassing | -550,00% | 0,00% | -314,29% | — |
Growth
Rev 5Y: -87,77% · Earnings 1Y: N/A
Growth
Rev 5Y: -87,77% · Earnings 1Y: N/A| Revenue Growth (1Y) | 494,61% | Revenue Growth (3Y) | -99,27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -87,77% | Earnings Growth (5Y) | N/A |
Profitability
ROE: N/A · Net Margin: -235580,56%
Profitability
ROE: N/A · Net Margin: -235580,56%| Revenue (TTM) | 2.979,0 | Net Income (TTM) | -7,02 M |
| ROE | N/A | ROA | -458,28% |
| Gross Margin | -937,93% | Operating Margin | -236084,16% |
| Net Margin | -235580,56% | Free Cash Flow (TTM) | -3,93 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 0,27
Safety
D/E: N/A · Current: 0,27| Debt / Equity | N/A | Current Ratio | 0,27 |
| Interest Coverage | -202,44 | Asset Turnover | 0,00 |
| Working Capital | -3,54 M | Tangible Book Value | -4,61 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -7,51 · EV/EBITDA: N/A
Valuation
P/E: -7,51 · EV/EBITDA: N/A| P/E Ratio | -7,51 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 17695,75 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7,45% | ||
| Market Cap | 52,72 M | Enterprise Value | 51,59 M |
Per Share
EPS: N/A · FCF/Share: 0,00
Per Share
EPS: N/A · FCF/Share: 0,00| EPS (Diluted TTM) | N/A | Revenue / Share | 0,00 |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 55,98% · CapEx/Rev: 1583,92%
Efficiency
FCF Conv: 55,98% · CapEx/Rev: 1583,92%| CapEx / Revenue | 1583,92% | FCF Conversion | 55,98% |
| SBC-Adj. FCF | -8,52 M | Growth Momentum | 582,38 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.979,0 | 501,0 | 55,69 M | 29,27 M | 13,32 M |
| Net Income | -7,02 M | -11,89 M | -18,48 M | -7,22 M | -4,04 M |
| EPS (Diluted) | — | — | 0,00 | 0,00 | 0,00 |
| Gross Profit | -27.941,0 | -66.305,0 | 20,35 M | 10,22 M | 5,29 M |
| Operating Income | -7,03 M | -8,50 M | -17,98 M | -8,65 M | -4,74 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | 32,22 M | — | 10,03 M |
| D&A | 47.817,0 | 1,14 M | 1,49 M | 1,06 M | 497.408,0 |
| Interest Expense | 34.741,0 | 126.000,0 | 211.996,0 | — | 65.281,0 |
| Income Tax | — | — | — | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,47 M | 2,22 M | 30,97 M | 55,26 M | 34,44 M |
| Total Liabilities | 1,59 M | 2,67 M | 23,10 M | 20,33 M | 5,21 M |
| Shareholders' Equity | -1,23 M | -1,56 M | 6,76 M | 20,21 M | 29,23 M |
| Total Debt | — | — | 3,56 M | 2,91 M | 421.455,0 |
| Cash & Equivalents | 1,14 M | 1,19 M | — | — | 26,50 M |
| Current Assets | 1,34 M | 1,95 M | 11,73 M | 30,31 M | 28,77 M |
| Current Liabilities | 1,59 M | 2,67 M | 12,23 M | 9,91 M | 2,52 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -7,5 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,7 |
| Net Margin % | -235580,6 | -41,5 |
| Rev Growth 5Y % | -87,8 | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"HCMC","listing_kind":"stock","pathname":"/stocks/hcmc","exchange":"OTC","country":"US"}}